Anyone pregnant, breastfeeding, or with a diagnosed metabolic, hepatic, or endocrine condition falls entirely outside any studied context and should not be a subject of self-directed use
They include pain or redness at the injection site, slight swelling or tenderness, mild diarrhea, and sometimes itching or a generalized feeling of body swelling
Insulin Syringes (U-100) Injectable Route Use 0.3 mL / 30-unit syringes for small daily draws (20 units for a 500 mcg dose at 2,500 mcg/mL)
Patients with existing liver conditions should disclose them during the medical intake
Glutathione, Detoxification, and Addiction Damage
What we know comes from preclinical toxicology and post-market surveillance of compounded products